Sarcoidosis

Xeljanz (Tofacitinib) Might Be Successful In Treating Sarcoidosis – Sarcoidosis News

Posted by Basil René on

Xeljanz is a partial inhibitor of the JAK enzyme that has been used off-label for the treatment of sarcoidosis and is being studied in clinical trials.
— Read on sarcoidosisnews.com/xeljanz-tofacitinib/

Published by Basil René

I maintain three separate blogs. One is LifeAsAnAnomaly.com where I discuss my life, AChefTalksFood.blog, where as the name implies, I talk about food and LifeCaptured.wordpress.com where I post photos.